← All trials
NCT07175415
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2026
- Primary completion
- Oct 1, 2031
- Completion date
- Oct 1, 2032
- First posted
- Sep 16, 2025
- Last posted
- Sep 16, 2025
- Enrollment
- 42
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Princess Maxima Center for Pediatric OncologyLead sponsor
- Humboldt UniversityOfficial
- AbbVieCollaborator
- AstraZenecaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.